A pretreatment nomogram to predict muscle-invasiveness in high-risk upper tract urothelial carcinoma (ROBUUST 2.0 collaborative group)
The proposed prognostic model is a valuable tool for estimating the risk of muscle-invasiveness in high-risk UTUC patients, owing to its optimal predictive ability and user-friendly design.
Authors
- Mark L. Gonzalgo (ORCID: https://orcid.org/0000-0003-0476-0288)
- Gabriele Tuderti (ORCID: https://orcid.org/0000-0003-4480-9090)
- Reuben Ben‐David (ORCID: https://orcid.org/0000-0001-7946-7145)
- Alireza Ghoreifi (ORCID: https://orcid.org/0000-0002-7368-7240)
- Reza Mehrazin (ORCID: https://orcid.org/0009-0007-8648-0410)
- Dhruv Puri (ORCID: https://orcid.org/0000-0001-6657-0135)
- Sisto Perdonà (ORCID: https://orcid.org/0000-0001-8683-4644)
- Farshad Sheybaee Moghaddam (ORCID: https://orcid.org/0000-0001-5360-0825)
- Courtney Yong (ORCID: https://orcid.org/0000-0002-7210-7558)
- Eugenio Bologna (ORCID: https://orcid.org/0000-0002-1140-0590)
- Riccardo Giuseppe Bertolo (ORCID: https://orcid.org/0000-0003-0260-4601)
- Enrico Checcucci (ORCID: https://orcid.org/0000-0001-7901-5608)
- Vitaly Margulis
- Marco Finati (ORCID: https://orcid.org/0000-0002-7425-1166)
- Sol C. Moon (ORCID: https://orcid.org/0009-0002-9299-0760)
- Andres Correa (ORCID: https://orcid.org/0000-0001-8506-7324)
- Daniele Amparore (ORCID: https://orcid.org/0000-0001-5425-5453)
- Ottavio De Cobelli (ORCID: https://orcid.org/0000-0002-0699-8620)
- Hooman Djaladat (ORCID: https://orcid.org/0000-0002-1984-3556)
- Emma Helstrom
- Riccardo Autorino (ORCID: https://orcid.org/0000-0001-7045-7725)
- Soroush Rais‐Bahrami (ORCID: https://orcid.org/0000-0001-9466-9925)
- Nirmish Singla
- Firas Abdollah (ORCID: https://orcid.org/0000-0003-1298-8231)
- Stephan Broenimann
- Antonio Franco
- Raj Bhanvadia (ORCID: https://orcid.org/0000-0003-3462-376X)
- Alessandro Antonelli (ORCID: https://orcid.org/0000-0002-7455-8803)
- Antonio Tufano (ORCID: https://orcid.org/0000-0003-4223-2216)
- Chandru P. Sundaram (ORCID: https://orcid.org/0000-0003-2885-1678)
- Dinno F. Mendiola
- F. Porpiglia (ORCID: https://orcid.org/0000-0002-0752-4857)
- Alessandro Veccia (ORCID: https://orcid.org/0000-0001-5947-3206)
- Ithaar Derweesh (ORCID: https://orcid.org/0000-0002-8673-0711)
- Linhui Wang (ORCID: https://orcid.org/0000-0002-6070-1832)
- Giuseppe Simone (ORCID: https://orcid.org/0000-0002-2560-4447)
- Zhenjie Wu (ORCID: https://orcid.org/0000-0002-6487-5207)
- Francesco Ditonno
- Matteo Ferro
Institutions
- University of Verona (IT)
- Fox Chase Cancer Center (US)
- University of Miami (US)
- Second Military Medical University (CN)
- Henry Ford Hospital (US)
- University of California San Diego (US)
- Mount Sinai Hospital (US)
- Changhai Hospital (CN)
- USC Norris Comprehensive Cancer Center (US)
- Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT)
- Miami Transplant Institute (US)
- Johns Hopkins Hospital (US)
- Candiolo Cancer Institute (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Rush University (US)
- Indiana University – Purdue University Indianapolis (US)
- European Institute of Oncology (IT)
- The University of Texas Southwestern Medical Center (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Minerva Urology and Nephrology
- Published
- 2025-04-01
- DOI
- https://doi.org/10.23736/s2724-6051.25.05934-8
- Citations
- 4
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 8.03